Thurston Springer Miller Herd & Titak Inc. Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,158 shares of the medical equipment provider’s stock after purchasing an additional 186 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in Intuitive Surgical were worth $569,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the second quarter valued at approximately $26,000. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC boosted its position in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. Delos Wealth Advisors LLC grew its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.6 %

NASDAQ ISRG opened at $487.61 on Tuesday. The stock has a market capitalization of $172.96 billion, a price-to-earnings ratio of 88.02, a PEG ratio of 5.40 and a beta of 1.39. The stock has a 50-day moving average of $481.33 and a 200 day moving average of $435.81. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ISRG shares. Barclays increased their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Truist Financial raised their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday. Raymond James boosted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday. Royal Bank of Canada raised their target price on Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Finally, Piper Sandler boosted their price target on Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $467.55.

Insider Activity

In related news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.